San Raffaele
Radioembolization for liver cancer in Italy typically costs from $45,000 to $70,000. The total price depends on the dosimetry approach, disease stage, and hospital facility tier. In the US, similar procedures cost around $190,000 on average. Patients save around 70% compared to the US market. Standard inclusions often cover the radioisotope, interventional radiology fees, and essential hospital stay.
Bookimed Expert Insight: Choosing a research-focused institution provides access to breakthrough protocols not found elsewhere. San Raffaele in Milan is a prime example of this value. It is an IRCCS-accredited facility combining clinical care with intensive research. This status ensures patients receive treatment based on the latest oncological data. With over 52,000 operations annually, their high volume often translates to more refined procedural efficiency.
Why do patients choose Italy for radioembolization for liver cancer?
Access advanced Radioembolization for liver cancer solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Radioembolization for liver cancer | from $45,000 | from $17,820 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Radioembolization for liver cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Radioembolization for liver cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Radioembolization for liver cancer journey.
Day 1: Arrival
Day 2: Pre-operation
Day 3: Radioembolization
Day 4: Post-operation
Week 1: Rehabilitation
Week 2 to 4: Rehabilitation
Please note that each patient"s journey to recovery may vary depending on their overall health, the size and location of the tumor, and their body"s response to the treatment.
The doctor is a hepatobiliary surgeon with over 25 years of experience and is a pioneer in minimally invasive liver surgery. They initiated and developed the San Raffaele laparoscopic liver resection program and currently serve as the Head of the Hepatobiliary and General Surgery Division at the San Raffaele Research Hospital in Milan. As the Scientific Director of the Italian Group of Minimally Invasive Liver Surgery, their clinical and research focus includes surgical oncology for colorectal liver metastases, cholangiocarcinoma, and hepatocellular carcinoma. The doctor has performed over 3,000 liver resections, with more than 900 laparoscopic procedures.
Radioembolization (SIRT) is available in Italy for treating primary liver cancer and colorectal metastases. Leading university hospitals and research institutes in Milan and Rome utilize Yttrium-90 microspheres (SIR-Spheres). These centers provide advanced interventional radiology for patients who are not candidates for surgery.
Bookimed Expert Insight: While Italy hosts top-tier research hospitals like San Raffaele, specialized SIRT availability is regionally concentrated. Large institutes often combine research with care, giving patients access to the latest clinical protocols. Patients should confirm which specific microsphere brand a hospital stocks before traveling for treatment.
Patient Consensus: Patients recommend contacting major centers like the National Cancer Institute directly to confirm current availability. Many suggest considering private options or cross-border care to avoid longer wait times in the public system.
Radioembolization is a two-step outpatient procedure for liver cancer involving a mapping session and Y-90 radioactive bead injection. Interventional radiologists guide a catheter via the groin or wrist into liver blood vessels. Microscopic beads then deliver targeted radiation directly to the tumor.
Bookimed Expert Insight: Italian research centers like San Raffaele in Milan combine clinical care with intensive IRCCS research. This ensures patients access specific technical expertise for complex vessel mapping. Some Italian clinics perform over 52,000 surgeries yearly, providing high volume confidence for this precise intervention.
Patient Consensus: Travelers often highlight that systemic side effects are minimal compared to traditional chemotherapy. Most feel ready for light activity within 1 week despite temporary fatigue or mild abdominal pain.
Radioembolization with Yttrium-90 serves as an effective bridge to liver transplant by controlling tumor growth. This locoregional therapy prevents waitlist dropout and downstages large tumors to meet Milan criteria. It currently surpasses traditional chemoembolization as the most utilized bridging method for hepatocellular carcinoma.
Bookimed Expert Insight: Italian research hospitals like San Raffaele in Milan combine clinical assistance with IRCCS research accreditation. Our data shows these centers manage over 52,000 operations annually. They often lead in multidisciplinary reviews for complex bridging cases. This research-heavy environment provides faster access to the latest protocols for patients with high tumor burdens.
Patient Consensus: Treatment can sustain waitlist eligibility for over 18 months by shrinking tumors significantly. Patients advise monitoring liver function closely as post-radiation fatigue can mimic liver failure symptoms.
Italy features world-class centers for radioembolization, specifically in Milan and Rome. Top facilities like San Raffaele Hospital and Policlinico Gemelli utilize multidisciplinary teams. These research-heavy institutions (IRCCS) provide Yttrium-90 (Y90) therapy and advanced SIRT under precise instrumental guidance for complex liver cases.
Bookimed Expert Insight: Data suggests focusing on high-volume hubs like Policlinico Gemelli and San Raffaele. These centers manage 100+ cases yearly. High volume tracks directly with lower post-procedure fatigue rates. At specialized hubs, fatigue drops significantly compared to smaller clinics. Choosing these IRCCS centers ensures access to mandatory national outcome registries.
Patient Consensus: Patients emphasize the importance of the pre-procedure mapping angiogram to prevent delays. Many recommend seeking a second opinion on dosimetry simulations to ensure accuracy.